Key facts
- Noviwest will focus on vitamins, carotenoids, and aroma ingredients.
- Panavora will focus on animal protein production solutions and feed additives.
- DSM-Firmenich will retain a 20% equity interest in both companies.
- CVC Capital Partners will acquire the two standalone companies.
DSM-Firmenich has announced that Noviwest™ and Panavora™ will be the names of the two independent companies formed from its Animal Nutrition & Health business. The sale to CVC Capital Partners is pending regulatory approvals and employee consultations, after which DSM-Firmenich will hold a 20% stake in each new entity. Noviwest will concentrate on essential ingredients like vitamins and carotenoids, emphasizing European manufacturing for supply chain resilience. Panavora will focus on sustainable animal protein production, offering innovative feed additives and digital solutions to improve animal health and performance. Both companies aim to serve customers independently while potentially collaborating where their capabilities complement each other.